首页> 外文期刊>Pharmacy Practice >Adherence to antiretroviral therapy and its determinants among persons living with HIV/AIDS in Bayelsa state, Nigeria
【24h】

Adherence to antiretroviral therapy and its determinants among persons living with HIV/AIDS in Bayelsa state, Nigeria

机译:尼日利亚巴耶尔萨州艾滋病毒/艾滋病感染者坚持抗逆转录病毒疗法及其决定因素

获取原文
           

摘要

Background : A high level of adherence is required to achieve the desired outcomes of antiretroviral therapy. There is paucity of information about adherence to combined antiretroviral therapy in Bayelsa State of southern Nigeria. Objectives : The objectives of the study were to determine the level of adherence to combined antiretroviral therapy among the patients, evaluate the improvement in their immune status and identify reasons for sub-optimal adherence to therapy. Methods : The cross-sectional study involved administration of an adapted and pretested questionnaire to 601 consented patients attending the two tertiary health institutions in Bayesla State, Nigeria: The Federal Medical Centre, Yenagoa and the Niger-Delta University Teaching Hospital Okolobiri. The tool was divided into various sections such as socio-demographic data, HIV knowledge and adherence to combined antiretroviral therapy. Information on the patient's CD4+ T cells count was retrieved from their medical records. Adherence was assessed by asking patients to recall their intake of prescribed doses in the last fourteen days and subjects who had 95-100% of the prescribed antiretroviral drugs were considered adherent. Results : Three hundred and forty eight (57.9%) of the subjects were females and 253 (42.1%) were males. The majority of them, 557 (92.7%) have good knowledge of HIV and combined anti-retroviral therapy with a score of 70.0% and above. A larger proportion of the respondents, 441 (73.4%), had ≥95% adherence. Some of the most important reasons giving for missing doses include, “simply forgot” 147 (24.5%), and “wanted to avoid the side-effects of drugs” 33(5.5%). There were remarkable improvements in the immune status of the subjects with an increment in the proportion of the subjects with CD4+ T cells count of greater than 350 cells/mm3 from 33 (5.5%) at therapy initiation to 338 (56.3%) at study period (p&0.0001). Conclusion : The adherence level of 73.4% was low which calls for intervention and improvement. The combined antiretroviral therapy has significantly improved the immune status of the majority of patients which must be sustained. “Simply forgot” was the most important reason for missing doses.
机译:背景:需要高水平的依从性才能获得抗逆转录病毒疗法的理想结果。在尼日利亚南部的巴耶尔萨州,缺乏有关坚持联合抗逆转录病毒疗法的信息。目的:该研究的目的是确定患者对联合抗逆转录病毒疗法的依从程度,评估其免疫状况的改善,并确定对治疗依从性不佳的原因。方法:该横断面研究涉及向参与尼日利亚贝叶斯拉州两个三级卫生机构的601名同意患者进行管理,经过预先测试的问卷调查,这两个机构分别是:耶拿哥州联邦医疗中心和尼日尔三角洲大学教学医院Okolobiri。该工具分为多个部分,例如社会人口统计学数据,HIV知识以及对联合抗逆转录病毒疗法的依从性。从患者的病历中检索有关患者CD4 + T细胞计数的信息。通过要求患者回忆最近十四天摄入的规定剂量来评估依从性,并且将服用95-100%的抗逆转录病毒药物的受试者视为依从性。结果:348名受试者(57.9%)为女性,253名受试者(42.1%)为男性。他们中的大多数(557名,占92.7%)对HIV具有良好的知识,并且联合抗逆转录病毒疗法的得分为70.0%或更高。较大比例的受访者441(73.4%)的依从性≥95%。减少剂量的一些最重要的原因包括:“简单地忘记” 147(24.5%)和“想要避免药物的副作用” 33(5.5%)。 CD4 + T细胞计数大于350细胞/ mm3的受试者比例从治疗开始时的33(5.5%)上升到研究期间的338(56.3%),受试者的免疫状况有了显着改善。 (p <0.0001)。结论:依从性较低,为73.4%,需要干预和改善。联合抗逆转录病毒疗法已大大改善了大多数必须维持的患者的免疫状况。 “完全忘记”是错过剂量的最重要原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号